BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 33765411)

  • 1. Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    White NJ; Strub-Wourgaft N; Faiz A; Guerin PJ
    Lancet; 2021 Apr; 397(10281):1262-1263. PubMed ID: 33765411
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
    Bos LDJ; Brodie D; Calfee CS
    JAMA Intern Med; 2021 Jan; 181(1):9-11. PubMed ID: 32945833
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe Covid-19.
    Berlin DA; Gulick RM; Martinez FJ
    N Engl J Med; 2020 Dec; 383(25):2451-2460. PubMed ID: 32412710
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio Interview: New Research on Possible Treatments for Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Mar; 382(12):e30. PubMed ID: 32187489
    [No Abstract]   [Full Text] [Related]  

  • 7. A Patient with Fever and Dyspnea.
    Matias WR; Vaidya A; Brigl M; Bebell LM
    N Engl J Med; 2020 Nov; 383(19):e111. PubMed ID: 33211933
    [No Abstract]   [Full Text] [Related]  

  • 8. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
    Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
    JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.
    Ye Z; Rochwerg B; Wang Y; Adhikari NK; Murthy S; Lamontagne F; Fowler RA; Qiu H; Wei L; Sang L; Loeb M; Shen N; Huang M; Jiang Z; Arabi YM; Colunga-Lozano LE; Jiang L; Koh Y; Liu D; Liu F; Phua J; Shen A; Huo T; Du B; Zhai S; Guyatt GH
    CMAJ; 2020 May; 192(20):E536-E545. PubMed ID: 32350002
    [No Abstract]   [Full Text] [Related]  

  • 11. Discussing Evidence in the Fog of the Pandemic.
    Hope AA; Munro CL
    Am J Crit Care; 2020 Jul; 29(4):246-248. PubMed ID: 32369547
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
    Ann Intern Med; 2021 Mar; 174(3):I16. PubMed ID: 33284685
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father.
    Vlachogianni G; Hassapopoulou-Matamis H; Politis C; Fylaki E; Mentis A
    Transfus Clin Biol; 2020 Nov; 27(4):269-270. PubMed ID: 33071174
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review.
    Subramanian K; Nalli A; Senthil V; Jain S; Nayak A; Bhat A
    Adv Ther; 2020 Oct; 37(10):4107-4131. PubMed ID: 32809210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
    Herth FJF; Sakoulas G; Haddad F
    Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient obstetric management of COVID-19.
    Aubey J; Zork N; Sheen JJ
    Semin Perinatol; 2020 Nov; 44(7):151280. PubMed ID: 32839010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.